Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)
Completed
- Conditions
- Spinal SpondyloarthropathiesAxial Spondyloarthritis
- Registration Number
- NCT00726765
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
This is a multi-national, multi-site, observational study to determine which of two strategies, when used by referring physicians is superior in the diagnosis of axial spondyloarthritis (AS) by rheumatologists.
- Detailed Description
Subjects will be selected using a non-probability sampling method. For each center of excellence, the local network of referring physicians will be assigned, according to a random code in a 1:1 ratio, to use one of the two referral strategies for eligible patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1090
Inclusion Criteria
- A subject must have back pain of unknown origin, of more than 3 months' duration, and with onset before age 45.
- A subject must be willing to give written informed consent and be able to adhere to visit schedules.
Read More
Exclusion Criteria
- Established diagnosis of spondyloarthropathies at the time of referral.
- Any clinically significant condition or situation, other than the condition being studied, that, in the opinion of the investigator, would interfere with the study evaluations or optimal participation in the study.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine which of two referral strategies, when used by referring physicians, is superior in the diagnosis of AS by rheumatologists. Approximately 3-6 months
- Secondary Outcome Measures
Name Time Method To determine which of the referral criteria proposed, or which combination of referral criteria, is the most successful and workable in the diagnosis of AS when used by referring physicians. Approximately 3-6 months To describe the demographics and disease characteristics of patients diagnosed with AS. Approximately 3-6 months To compare patient-derived data with physician data to determine whether the former alone can serve as effective screening for AS. Approximately 3-6 months